SUNWELS Co.,Ltd. (JP:9229)
:9229
Want to see JP:9229 full AI Analyst Report?
Top Page
SUNWELS Co.,Ltd.
(9229)
Select Model
Select Model
Rating:42Neutral
Price Target:
¥189.00
▼(-44.90% Downside)
Action:Reiterated
Date:05/14/26
The score is primarily driven by weak financial performance: profitability has broken down, leverage has increased materially, and cash generation has deteriorated with negative operating cash flow and persistent negative free cash flow. Technicals also remain strongly bearish with the stock trading below all major moving averages and negative momentum indicators. Valuation offers limited support due to losses (negative P/E) and no reported dividend yield.
Positive Factors
Exposure to eldercare sector (structural demand)
SUNWELS' core business in healthcare and eldercare aligns with long-term demographic demand for aging services. This structural market supports recurring, utilization-driven revenue and steady demand for care capacity, underpinning revenue durability over the next 2–6 months.
Negative Factors
Severe margin compression and operating losses
Gross margin collapse to ~9.8% and the shift to an operating loss indicate lasting pressure on core service profitability. Persistently weaker margins undermine the business's ability to convert revenue into sustainable earnings and may necessitate restructuring or price/service adjustments to restore unit economics.
Read all positive and negative factors
Positive Factors
Negative Factors
Exposure to eldercare sector (structural demand)
SUNWELS' core business in healthcare and eldercare aligns with long-term demographic demand for aging services. This structural market supports recurring, utilization-driven revenue and steady demand for care capacity, underpinning revenue durability over the next 2–6 months.
Read all positive factors
SUNWELS Co.,Ltd. (9229) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥6.73B
Dividend YieldN/A
Average Volume (3M)115.88K
Price to Earnings (P/E)―
Beta (1Y)1.13
Revenue Growth6.19%
EPS Growth-80.97%
CountryJP
Employees2,435
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)-54.63
Shares Outstanding35,220,000
10 Day Avg. Volume157,720
30 Day Avg. Volume115,876
Financial Highlights & Ratios
PEG Ratio-0.06
Price to Book (P/B)1.15
Price to Sales (P/S)0.28
P/FCF Ratio-5.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-27.7
Revenue Forecast (FY)¥32.00B
SUNWELS Co.,Ltd. Business Overview & Revenue Model
Company Description
Sunwels Co.,Ltd. operates nursing care business centered on PD house. It operates homes for the elderly that specializes in Parkinson disease, as well as a Kaatsu training gym; provides day care, in-home care support, care plan, and home remodelin...
How the Company Makes Money
null...
SUNWELS Co.,Ltd. Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
24
Negative
Cash Flow
22
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 26.86B | 28.14B | 26.50B | 20.11B | 13.24B | 8.17B |
| Gross Profit | 3.99B | 2.76B | 4.89B | 5.13B | 3.24B | 1.60B |
| EBITDA | 1.54B | 639.00M | 2.50B | 3.09B | 1.45B | 557.48M |
| Net Income | -1.77B | -1.66B | -925.00M | 802.00M | 303.60M | 10.65M |
Balance Sheet | ||||||
| Total Assets | 42.22B | 45.63B | 39.44B | 31.74B | 19.30B | 9.10B |
| Cash, Cash Equivalents and Short-Term Investments | 3.62B | 4.09B | 5.64B | 3.31B | 2.61B | 814.76M |
| Total Debt | 26.35B | 29.11B | 22.49B | 20.11B | 11.20B | 6.60B |
| Total Liabilities | 34.32B | 38.66B | 30.82B | 26.54B | 14.69B | 8.52B |
| Stockholders Equity | 7.89B | 6.97B | 8.62B | 5.20B | 4.61B | 580.80M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.50B | -2.32B | -2.93B | -740.86M | -73.95M |
| Operating Cash Flow | 0.00 | -332.00M | 1.88B | 2.56B | 1.14B | 378.19M |
| Investing Cash Flow | 0.00 | -1.27B | -4.40B | -5.66B | -2.04B | -633.05M |
| Financing Cash Flow | 0.00 | 62.00M | 4.84B | 3.80B | 2.70B | 573.26M |
SUNWELS Co.,Ltd. Technical Analysis
Neutral
343.00
Price Trends
264.60
Negative
322.15
Negative
494.70
Negative
Market Momentum
-5.76
Negative
48.30
Neutral
57.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9229, the sentiment is Neutral. The current price of 343 is above the 20-day moving average (MA) of 248.75, above the 50-day MA of 264.60, and below the 200-day MA of 494.70, indicating a neutral trend. The MACD of -5.76 indicates Negative momentum. The RSI at 48.30 is Neutral, neither overbought nor oversold. The STOCH value of 57.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:9229.
SUNWELS Co.,Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ¥3.01B | 4.69 | ― | 2.82% | 5.16% | 19.94% | |
68 Neutral | ¥105.35B | 27.32 | ― | 2.47% | 2.70% | -4.93% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥5.56B | 23.20 | ― | 4.07% | 4.75% | 20.56% | |
51 Neutral | ¥2.78B | 24.82 | ― | 2.56% | -6.54% | -69.23% | |
45 Neutral | ¥6.13B | 19.08 | ― | 1.41% | 16.83% | -45.33% | |
42 Neutral | ¥6.73B | -4.84 | ― | ― | 6.19% | -80.97% |
* Healthcare Sector Average
JP:9229
SUNWELS Co.,Ltd.
191.00
-339.00
-63.96%
JP:2373
Care Twentyone Corporation
413.00
28.02
7.28%
JP:2425
Care Service Co., Ltd.
733.00
-38.83
-5.03%
JP:6197
Solasto Corp.
1,112.00
699.28
169.43%
JP:7061
Japan Hospice Holdings Inc.
725.00
-423.08
-36.85%
JP:9220
FB CARE SERVICE CO.,LTD.
1,236.00
278.87
29.14%
SUNWELS Co.,Ltd. Corporate Events
SUNWELS Corrects Per-Share Data in FY2026 Non-Consolidated Results
May 13, 2026
SUNWELS Co., Ltd. announced that it has corrected errors in its previously released non-consolidated financial results for the fiscal year ended March 31, 2026, prepared under Japanese GAAP. The revisions affect per-share indicators, including net...
SUNWELS Scraps Year-End Dividend After Posting ¥1.66 Billion Net Loss
May 12, 2026
SUNWELS Co., Ltd. has announced that its board of directors resolved not to pay a year-end dividend for the fiscal year ended March 31, 2026, maintaining a dividend per share of zero yen as in the previous year. The decision follows the company...
Sunwels outlines FY March 2026 results and care-focused growth strategy
May 12, 2026
Sunwels Co., Ltd. released financial highlights for the fiscal year ending March 2026 alongside an overview of its business profile centered on healthcare and caregiving services. The company emphasized initiatives like its specialized ‘PD H...
SUNWELS Swings to Loss Despite Higher Sales, Signals Gradual Earnings Recovery
May 12, 2026
SUNWELS Co., Ltd. reported a 6.2% rise in net sales to ¥28.1 billion for the year ended March 31, 2026, but swung to an operating loss of ¥1.2 billion and an ordinary loss of ¥2.2 billion, resulting in a net loss of ¥1.7 billio...
SUNWELS Faces Added TSE Supervision as It Seeks Shift to Standard Market
Apr 30, 2026
SUNWELS Co., Ltd. reported that the Tokyo Stock Exchange will add a new reason for designating its shares as Securities Under Supervision (Examination) from May 1, 2026, linked to a prior violation of a written pledge and its ongoing preliminary a...
SUNWELS Defers Loan Principal and Redirects Equity Proceeds to Working Capital
Apr 21, 2026
SUNWELS has secured agreement from nine financial institutions to defer principal repayments totaling ¥574 million falling due between April 30 and September 30, 2026, while continuing to pay interest. The company positions the year to March ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.